Page last updated: 2024-10-25

cx546 and Cognition Disorders

cx546 has been researched along with Cognition Disorders in 2 studies

1-(1,4-benzodioxan-6-ylcarbonyl)piperidine: structure in first source

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research Excerpts

ExcerptRelevanceReference
"Autism is a neurodevelopmental disorder in which the first diagnostic symptom is unusual reciprocal social interactions."1.39AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. ( Crawley, JN; Gastrell, PT; Karras, MN; Oliver, CF; Silverman, JL, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silverman, JL1
Oliver, CF1
Karras, MN1
Gastrell, PT1
Crawley, JN1
Lynch, G1

Reviews

1 review available for cx546 and Cognition Disorders

ArticleYear
Glutamate-based therapeutic approaches: ampakines.
    Current opinion in pharmacology, 2006, Volume: 6, Issue:1

    Topics: Animals; Brain; Cognition Disorders; Dioxoles; Drug Evaluation, Preclinical; Excitatory Amino Acid A

2006

Other Studies

1 other study available for cx546 and Cognition Disorders

ArticleYear
AMPAKINE enhancement of social interaction in the BTBR mouse model of autism.
    Neuropharmacology, 2013, Volume: 64

    Topics: Animals; Autistic Disorder; Behavior, Animal; Cognition Disorders; Dioxoles; Disease Models, Animal;

2013